The health authority’s decision was the final approval necessary for the merger to proceed.
The Federal Trade Commission raised objections to the proposed merger on two separate occasions, stating the merger would increase costs for patients and decrease the quality of care. Officials from both hospitals responded, saying the FTC’s view on the merger is “very narrow” and only focused on the competition.
Officials said the merged entity would be named Ballad Health.
More articles on transactions and valuations:
Trending: More children’s hospitals are partnering with local facilities
This week’s 5 most-read transactions and valuations stories
MedPac discusses policy options in light of consolidation trend
